Lexaria Bioscience (LEXX) Change in Inventory (2014 - 2023)
Lexaria Bioscience's (LEXX) quarterly Change in Inventory came in at -$76782.0 in Q2 2023, down 641.35% year-on-year from $14183.3 in Q2 2022, and down 219.03% quarter-over-quarter from $64504.0 in Q1 2023.
Lexaria Bioscience (LEXX) Change in Inventory (2014 - 2023) Analysis & Trends
Lexaria Bioscience has disclosed Change in Inventory across 10 years of filings, most recently posting -$76782.0 for Q2 2023.
- Change in Inventory for Q2 2023 came in at -$76782.0, down 641.35% year-over-year; the trailing twelve-month figure through Feb 2024 was -$76782.0 (down 351.14% YoY), and the FY2023 annual result was -$43069.0, down 2076.3% from the prior year.
- Change in Inventory came in at -$76782.0 for Q2 2023 at Lexaria Bioscience, down from $64504.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $80257.0 in Q2 2019 to a low of -$88859.0 in Q2 2021.
- The 5-year median for Change in Inventory is -$5782.0 (2019), against an average of -$6553.4.
- Across the five-year window, Change in Inventory tumbled 956.66% in 2022 and jumped 1482.92% in 2023, its largest moves.
- Lexaria Bioscience's Change in Inventory stood at $6160.0 in 2019, then slipped by 1.51% to $6067.0 in 2020, then slumped by 148.03% to -$2914.0 in 2021, then sank by 956.66% to -$30791.0 in 2022, then tumbled by 149.37% to -$76782.0 in 2023.
- The last three Change in Inventory figures came in at -$76782.0 (Q2 2023), $64504.0 (Q1 2023), and -$30791.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Lexaria Bioscience | 7.17 Mn | 1.65 Mn | 20,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2023 | -76,782.00 |
| May 31, 2023 | -76,782.00 |
| Feb 28, 2023 | 64,504.00 |
| Feb 28, 2023 | 64,504.00 |
| Nov 30, 2022 | -30,791.00 |
| Nov 30, 2022 | -30,791.00 |
| Aug 31, 2022 | 7,217.00 |
| Aug 31, 2022 | 7,217.00 |
| May 31, 2022 | -10,357.00 |
| May 31, 2022 | -10,357.00 |
| Feb 28, 2022 | 4,075.00 |
| Feb 28, 2022 | 4,075.00 |
| Nov 30, 2021 | -2,914.00 |
| Nov 30, 2021 | -2,914.00 |
| Aug 31, 2021 | -23,061.00 |
| Aug 31, 2021 | -23,061.00 |
| May 31, 2021 | -88,859.00 |
| May 31, 2021 | -88,859.00 |
| Feb 28, 2021 | 10,816.00 |
| Feb 28, 2021 | 10,816.00 |